Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial).

Journal: Journal of acquired immune deficiency syndromes (1999)

Publication date: 2023

Journal: Journal of acquired immune deficiency syndromes (1999)

Publication Year: 2023

Authors & Co-authors:  Bousmah Marwân-Al-Qays MA Protopopescu Camelia C Mpoudi-Etame Mireille M Omgba Bassega Pierrette P Maradan Gwenaëlle G Olinga Justin J Varloteaux Marie M Tovar-Sanchez Tamara T Delaporte Éric É Kouanfack Charles C